Pre-Made Anatumomab Mafenatox biosimilar, Fusion Protein: Anatumomab-Anti-TAG-72 therapeutic antibody fused with Staphylococcus aureus enterotoxin A for drug discovery and mechanism of action (MOA) research

Pre-Made Anatumomab Mafenatox biosimilar, Fusion Protein: Anatumomab-Anti-TAG-72 therapeutic antibody fused with Staphylococcus aureus enterotoxin A is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.

Anatumomab mafenatox is a mouse monoclonal antibody studied for the treatment non-small cell lung cancer,[1] which acts as a tumor-targeted superantigen.[2]

Order information

* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry

Catalog No.	Package	Price(In USD)	Qty (Quantity)	Sum(In USD)
GMP-Bios-INN-733-1mg	1mg	3090
GMP-Bios-INN-733-10mg	10mg	Inquiry
GMP-Bios-INN-733-100mg	100mg	Inquiry
GMP-Bios-INN-733-xmg	≥100mg	Inquiry
			Shipping Cost:	760.00
			Total:

Description

Products Name (INN Index)	Pre-Made Anatumomab Mafenatox biosimilar, Fusion Protein: Anatumomab-Anti-TAG-72 therapeutic antibody fused with Staphylococcus aureus enterotoxin A
INN Name	Anatumomab Mafenatox
Target	TAG-72
Format	Fusion Protein
Derivation	Mus musculus
Species Reactivity	human
CH1 Isotype	Fab - G1 - kappa
VD LC	Fab - G1 - kappa
Highest_Clin_Trial (Jan '20)
Est. Status
100% SI Structure
99% SI Structure
95-98% SI Structure
Year Proposed
Year Recommended
Companies	0
Conditions Approved
Conditions Active
Conditions Discontinued
Development Tech	0